BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24811391)

  • 1. Association of high-sensitivity cardiac troponin T and N-terminal pro-brain-type natriuretic peptide with left ventricular structure: J-HOP study.
    Hoshide S; Nagai M; Yano Y; Ishikawa J; Eguchi K; Kario K;
    J Clin Hypertens (Greenwich); 2014 May; 16(5):354-61. PubMed ID: 24811391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.
    Kim Y; Matsushita K; Sang Y; Grams ME; Skali H; Shah AM; Hoogeveen RC; Solomon SD; Ballantyne CM; Coresh J
    Am J Kidney Dis; 2015 Apr; 65(4):550-8. PubMed ID: 25446023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with baseline and serial changes in circulating NT-proBNP and high-sensitivity cardiac troponin T in a population-based cohort (Dallas Heart Study).
    Puleo CW; Ayers CR; Garg S; Neeland IJ; Lewis AA; Pandey A; Drazner MH; de Lemos JA
    Biomark Med; 2021 Nov; 15(16):1487-1498. PubMed ID: 34663078
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC]).
    Mishra RK; Li Y; Ricardo AC; Yang W; Keane M; Cuevas M; Christenson R; deFilippi C; Chen J; He J; Kallem RR; Raj DS; Schelling JR; Wright J; Go AS; Shlipak MG;
    Am J Cardiol; 2013 Feb; 111(3):432-8. PubMed ID: 23178053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
    Pareek M
    Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of High-Sensitivity Cardiac Troponin and Natriuretic Peptide With Subsequent Risk of Infection in Persons Without Cardiovascular Disease: The Atherosclerosis Risk in Communities Study.
    Ishigami J; Hoogeveen RC; Ballantyne CM; Folsom AR; Coresh J; Selvin E; Matsushita K
    Am J Epidemiol; 2019 Dec; 188(12):2146-2155. PubMed ID: 31063194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical Cardiovascular Disease and Fall Risk in Older Adults: Results From the Atherosclerosis Risk in Communities Study.
    Juraschek SP; Daya N; Appel LJ; Miller ER; Matsushita K; Michos ED; Windham BG; Ballantyne CM; Selvin E
    J Am Geriatr Soc; 2019 Sep; 67(9):1795-1802. PubMed ID: 31493355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of prognostic values of high-sensitivity cardiac troponin T and N-terminal prohormone brain natriuretic peptide to assess mortality in elderly inpatients.
    Chen JR; Wang Q; Wu W; Zhang SJ
    Clin Interv Aging; 2019; 14():81-90. PubMed ID: 30643397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart failure in community-dwelling older adults at low baseline risk.
    Glick D; deFilippi CR; Christenson R; Gottdiener JS; Seliger SL
    JACC Heart Fail; 2013 Aug; 1(4):353-360. PubMed ID: 24621939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Sensitive Troponin T, Natriuretic Peptide, and Cognitive Change.
    Pokharel Y; Mouhanna F; Schneider ALC; Rawlings AM; Knopman DS; Nambi V; Virani SS; Hoogeveen RC; Alonso A; Heiss G; Coresh J; Mosley T; Gottesman R; Selvin E; Ballantyne C; Power MC
    J Am Geriatr Soc; 2019 Nov; 67(11):2353-2361. PubMed ID: 31359423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements.
    Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
    Clin Chem; 2010 Nov; 56(11):1718-24. PubMed ID: 20844063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide.
    Avouac J; Meune C; Chenevier-Gobeaux C; Borderie D; Lefevre G; Kahan A; Allanore Y
    Arthritis Care Res (Hoboken); 2015 Jul; 67(7):1022-30. PubMed ID: 25604469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between high-sensitivity cardiac troponin T and future cardiovascular incidence in a general Japanese population: results from the Tohoku medical megabank project.
    Takahashi Y; Satoh M; Ohmomo H; Tanaka F; Osaki T; Tanno K; Nasu T; Sakata K; Morino Y; Sobue K; Sasaki M
    Biomarkers; 2019 Sep; 24(6):566-573. PubMed ID: 30978115
    [No Abstract]   [Full Text] [Related]  

  • 14. Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.
    Neeland IJ; Drazner MH; Berry JD; Ayers CR; deFilippi C; Seliger SL; Nambi V; McGuire DK; Omland T; de Lemos JA
    J Am Coll Cardiol; 2013 Jan; 61(2):187-95. PubMed ID: 23219305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of Isolated Systolic Hypertension and Pulse Pressure to High-Sensitivity Cardiac Troponin-T and N-Terminal pro-B-Type Natriuretic Peptide in Older Adults (from the Atherosclerosis Risk in Communities Study).
    Madan N; Lee AK; Matsushita K; Hoogeveen RC; Ballantyne CM; Selvin E; McEvoy JW
    Am J Cardiol; 2019 Jul; 124(2):245-252. PubMed ID: 31088661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors.
    Avouac J; Meune C; Chenevier-Gobeaux C; Dieudé P; Borderie D; Lefevre G; Kahan A; Allanore Y
    J Rheumatol; 2014 Feb; 41(2):248-55. PubMed ID: 24334650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
    Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide in acute heart failure: Data from the ACE 2 study.
    Berge K; Lyngbakken MN; Myhre PL; Brynildsen J; Røysland R; Strand H; Christensen G; Høiseth AD; Omland T; Røsjø H
    Clin Biochem; 2021 Feb; 88():30-36. PubMed ID: 33245872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study.
    Dadu RT; Fornage M; Virani SS; Nambi V; Hoogeveen RC; Boerwinkle E; Alonso A; Gottesman RF; Mosley TH; Ballantyne CM
    Stroke; 2013 Jul; 44(7):1803-8. PubMed ID: 23660848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study.
    Bosello S; De Luca G; Berardi G; Canestrari G; de Waure C; Gabrielli FA; Di Mario C; Forni F; Gremese E; Ferraccioli G
    Eur J Intern Med; 2019 Feb; 60():46-53. PubMed ID: 30366614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.